Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

• Status: Completed
• Trial end date: 2008-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to evaluate the satisfaction level of patients using the Symbicort SMART approach for their asthma management.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Budesonide, Formoterol Fumarate Drug Combination

Criteria

Inclusion Criteria:

• Diagnosis of asthma for past 6 months and treated with inhaled glucocorticosteroids for at least 3 months.

• Patients who asthma is classified as uncontrolled or partially controlled as defined by GINA 2006 guidelines.

Exclusion Criteria:

• Patients already on Symbicort SMART treatment.

• Patients who has respiratory tract infection 30 days before study enrolment.